All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, April 1, 2023
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Telehealth illustration

COVID-19 changing the landscape of health care

April 30, 2020
By Mari Serebrov
No Comments
How U.S. health care emerges from the COVID-19 pandemic is a million-dollar question, as patients, providers, payers and drug manufacturers are adapting to a new reality that’s advancing telehealth and changing how providers interact with patients.
Read More
Lyme disease bacteria, Borrelia burgdorferi, transmitted by Ixodes tick

Valneva banks $130M as Pfizer buys into Lyme disease vaccine program

April 30, 2020
By Cormac Sheridan
No Comments
DUBLIN – Shares in Valneva SE rose by as much as 32% during early trading April 30 on news that Pfizer Inc. is paying $130 million up front to in-license its Lyme disease candidate vaccine, VLA-15.
Read More

Regulatory actions for April 30, 2020

April 30, 2020
No Comments
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acasti, Akarx, Alpha Cognition, Annovis Bio, Banner Life Sciences, Biocardia, Dova, Galectin, Genmab, Glaxosmithkline, Inmed, Junshi, Marker, Medivir, Neon, Pharming, Seelos, Zentalis.
Read More

Other news to note for April 30, 2020

April 30, 2020
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acelrx, Affibody, Ajinomoto, Aravive, Astrazeneca, Atreca, Bavarian Nordic, Beigene, Bioage Labs, Biosig, Bioinvent, Biostem, Cytodyn, Daewoong Pharmaceutical, Fujifilm Diosynth, Geovax, IGM Biosciences, Inovio, Just-Evotec, Ology, Oxford Biodynamics, PDS, Pfizer, Promis, Siga, Sprint, Sino Biological, Stabilitech, Taisho Pharmaceutical, Trio, Union, Vaxart, Viralclear, Wuxi, Xortx.
Read More

In the clinic for April 30, 2020

April 30, 2020
No Comments
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agios, Bellus, Gilead, GSK, Janssen, Jazz, Leo, Lilly, Mallinckrodt, Mesoblast, Morphosys, Novartis, Palatin, Sanofi, Silence, Soligenix, Spectrum, Urogen, Vertex, Yuhan.
Read More
Chronolife-Keesense-shirt.png

Chronolife scores win in Europe with Keesense remote health-monitoring platform

April 29, 2020
By Liz Hollis
No Comments
Artificial intelligence-focused Chronolife SAS, of Paris, has secured class IIa medical certification from the EU for its smart T-shirt, which has the new brand name Keesense. The reusable, washable T-shirt is designed for comfortable, round-the-clock use. It works by transmitting data to a paired smartphone app via Bluetooth.
Read More

Regulatory front for April 29, 2020

April 29, 2020
No Comments
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Refocus Group, Venner Medical.
Read More

Regulatory action for April 29, 2020

April 29, 2020
No Comments
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Diatherix, Medtronic, Photopharmics, Psychemedics, Senseonics, Vuno.
Read More

Other news to note for April 29, 2020

April 29, 2020
No Comments
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alivecor, Bioiq, Canon Medical Systems, Centene, Current Health, Dexcom, DFP Healthcare Acquisitions, ELT Sight, Intersystems, Labcorp, Masimo, Matrix Medical Network, Mayo Clinic, Medable, Medical Diagnostic Laboratories, Medplace, Mindray, Proteogenix, Pure Health, Quest Diagnostics, Seasun, Soc Telemed, Tmk Manufacturing, Trinity Health, Vander-Bend, Windtree.
Read More

BioWorld MedTech’s Orthopedics Extra for April 29, 2020

April 29, 2020
By Holland Johnson
No Comments
Keeping you up to date on recent developments in orthopedics, including: Physio support in COVID-19 recovery; Co-delivery of IL-10 and NT-3 to enhance spinal cord injury repair; European countries face a costly 23% increase in fragility fractures by 2030.
Read More
Previous 1 2 … 423 424 425 426 427 428 429 430 431 … 503 504 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 31, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for March 31, 2023.
  • Mbiomics raises €13M to pivot to microbiome-based therapeutic development

    BioWorld
    Mbiomics GmbH raised €13 million (US$14.2 million) in a first close of a series A round that will enable it to pivot from being a microbiome analytics firm to...
  • Bio-Europe Spring 2023: Despite funding woes, biotechs weather the storm with deals

    BioWorld
    Are deals such as M&As between biotechs and big pharma becoming a thing of the past? That was a key question posed during the opening keynote at this year’s...
  • Biohaven acquires early stage TYK2/JAK1 inhibitor from Highlightll in $970M deal

    BioWorld
    Biohaven Ltd. has acquired global rights, excluding China, from Highlightll Pharmaceutical Co. Ltd. to develop and commercialize a dual inhibitor of tyrosine...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing